{"disease":{"id":"aiha-cold-autoimmune-hemolytic-anemia","name":"aiha cold autoimmune hemolytic anemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07019038","title":"National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia","phase":"","overall_status":"RECRUITING","enrollment_count":9999,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06847607","title":"A Multicenter Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Bing Han","has_results":false},{"nct_id":"NCT07091370","title":"Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Juventas Cell Therapy Ltd.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}